Skip to content

Metabolic effects of survodutide in DIO mice at thermoneutrality

  • Allison Butt

Background & aim: Survodutide is a dual agonist of the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), currently in clinical development for obesity and related metabolic disorders. By concurrently enhancing GCGR and GLP1R signaling, survodutide offers a synergistic approach…

Read more
Back To Top